Tag: Vaccination

The one with a Nobel prize winner

Hadi Sallah, PhD student in John Tregoning's lab, working on RNA vaccines.
Hadi Sallah, PhD student in John Tregoning’s lab, working on RNA vaccines.

Dr John Tregoning, Professor in Vaccine Immunology, recounts his experience of working with Dr Katalin Karikó, Nobel Prize winner and the tenacious force behind the mRNA vaccines that helped change the course of the COVID-19 pandemic. Their recently published study investigates how RNA modifications impact the body’s immune response to infection, with the hopes of aiding the development of more effective mRNA vaccines.


Science is collaborative, we work with lots of different people to understand the world around us. Working with other people is one of the joys of the job. In our recently published study, Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice, we had the privilege of working with Dr Katalin Karikó, joint winner of the 2023 Nobel prize in Physiology or Medicine.

(more…)

Covid-19 vaccination in the UK: What does the future hold?

Covid-19 vaccination centre sign

Recently, the UK Government announced that offers of first and second Covid-19 vaccinations will come to an end after 30 June. Ahead of World Immunisation Week, Professor Azeem Majeed from the School of Public Health discusses this major change in national vaccine policy, and why it’s important to stay up to date with Covid-19 booster vaccinations.


The announcement from NHS England that first and second doses of Covid-19 vaccines will no longer be offered to adults after 30 June 2023 signifies a significant change in national vaccine policy. We will all remember the start of the Covid-19 vaccination programme in December 2020, the rapid rollout of vaccines by the NHS, and the enthusiasm for vaccination amongst most sections of the population. Vaccination curbed the impact of Covid-19, leading to large falls in hospital admissions and deaths, and allowing the government to end Covid-19 restrictions.

We are now though entering a new phase in which Covid-19 vaccination will be restricted to older people and those in medical problems that place them at higher risk of adverse outcomes such as hospitalisation and death. The very highest risk groups – such as the immunocompromised and people aged 75 years and over – have been offered booster vaccines every six months for the past two years. Other population groups – such as NHS staff, those aged 50 and over, and people with significant medical problems – have been offered annual booster vaccines.

(more…)

Is an H5N1 ‘bird flu’ pandemic inevitable?

The largest ever outbreak of bird flu is spilling over into mammals, including foxes and otters in the UK. Could this transmission see a jump to humans? Dr Thomas Peacock from the Department of Infectious Disease discusses.


Avian influenza virus has been featured prominently in the news again over the past few months. Headlines urge vaccine stockpiling, show images of beaches covered in dead sea birds or seals, or people in hazmat suits carrying bin bags full of dead birds or mink. Three years into the COVID-19 pandemic, is another pandemic unavoidable?

We have been in this situation before, back in the late 1990s and early 2000s, headlines spoke of ‘bird flu’ – H5N1 viruses ancestral to the ones currently circulating in Europe – as the inevitable coming pandemic. In fact, in 2009 an influenza pandemic did occur, but rather than the deadly H5N1 bird flu, it was caused by an obscure swine influenza virus that passed onto humans and caused the 2009 ‘swine flu’ pandemic.

(more…)

An intense, scientifically incredible journey – our response to COVID-19

This festive period Three Wise Women from the Faculty of Medicine will be giving us the gift of wisdom.

Dr Natsuko Imai reflects on the experience of supporting the Imperial College COVID-19 Response Team who provide key epidemiological insights to help inform the response to the pandemic.


Despite the introduction of “plan B”, I’m sure many of you will agree with me that, the run-up to Christmas this year still feels very different compared to 2020 when non-essential shops were closed, and we could only meet within our households or support bubbles. The swift introduction of measures and the fact we even have a vaccination programme to accelerate in response to the Omicron variant helps to keep me cautiously optimistic.

My colleagues in the MRC Centre for Global Infectious Disease Analysis and I have been working on COVID-19 since January 2020. This was when the virus was still called “novel coronavirus 2019” and only a handful of cases had been reported outside of mainland China. Since our early assessment of the transmissibility and true size of the epidemic in Wuhan City, the SARS-CoV-2 virus has spread to every corner of the world, changing the way we live in ways we could never have imagined.

Before the pandemic, most of my work as the liaison between the Centre and the World Health Organization was co-ordinating analytical support for outbreaks, typically in low- and middle-income countries. Since 2018, I have worked with colleagues on Ebola outbreaks in the Democratic Republic of the Congo, doing rapid real-time analysis to understand – “how bad is the outbreak? How many cases can we expect in the next 3-4 weeks? How many vaccines need to be deployed?”.

This year, I have worked on events closer to home, supporting the Centre’s Imperial College COVID-19 response team who provide key epidemiological insights to help inform the response to COVID-19 both in the UK and abroad. With requests for analysis coming in almost daily in the early days, it has been an intense, but scientifically incredible journey. I am especially thankful for the generosity everyone has shown under all kinds of pressures. (more…)

Standing up for the facts: COVID-19 vaccination, fertility and pregnancy

This festive period Three Wise Women from the Faculty of Medicine will be giving us the gift of wisdom.

Dr Viki Male explains how she took matters into her own hands in response to the mixed messaging around COVID-19 vaccination advice and pregnancy.


In 2003, the world was on the brink of a SARS-1 pandemic. As a Year 12 student at the time, I followed developments closely. Although the outbreak eventually died out, my interest in infectious diseases did not. Surely, the big one was coming. And I would be ready for it.

But by the time the big one came, my research has taken me in a different direction. At university, I had become passionately interested in a family of immune cells, called NK cells, that control viral infection. But these cells have another role that captured my imagination: they help the placenta to implant during pregnancy, and my lab is working out how. In March 2020, as immunologists around the world raced to make a vaccine, I shut my lab and went home to spend the next 12 weeks home-schooling my children. I would sit this one out. What use is a reproductive immunologist in a pandemic, anyway?

Some use, it turned out. In December 2020, as the vaccine rollout began, rumours started to circulate that antibodies raised by COVID-19 vaccination would target a placental protein, called Syncytin-1, causing infertility and miscarriages. There was no basis to this claim and if I, a reproductive immunologist, wouldn’t stand up and explain why, then what was the point of me? So I began engaging with the public, first on social media and then in print and broadcast. Here’s what they taught me… (more…)

How reconstructing the past hepatitis B epidemic can help prevent liver cancer in the future

Nora Schmit was shortlisted for the MRC Max Perutz Science Writing Award 2019 for the following article on her PhD research on predicting the impact of treatment for hepatitis B infection on preventing liver cancer in The Gambia.


What’s the first thing that comes to your mind when you think of cancer prevention? Maybe you’re thinking of not smoking or maintaining a healthy weight – great strategies to reduce your chance of getting cancer.

But did you know that the hepatitis B vaccine, introduced in the 1980s, has long protected children in many parts of the world from developing one of the most common and deadliest cancers later in life?

Although most people have no symptoms when they first become infected, the hepatitis B virus is the leading cause of liver cancer worldwide. Large-scale efforts to tackle the virus using vaccination have been hugely successful in preventing infections in children. Despite this remarkable achievement, hepatitis B infections are still very common and nearly a million people die from its consequences every year. With around 6% of all people living in Africa currently infected, the death toll there is expected to rise even further.

But while a liver cancer diagnosis is nearly always fatal, treating the infection is possible with the same drugs that work against HIV. So why do so few people receive these drugs, when over half of all liver cancer deaths globally are preventable? (more…)

Nature wants you dead – here’s how vaccines work to help keep us all alive

 

Dr John Tregoning takes us on a tour of vaccination’s greatest successes, explaining how this incredible human achievement works to keep us all safer from disease – as long as we keep vaccinating ourselves and our families.


Nature wants you dead. Not just you, but your children and unborn children and everyone you have ever met.

It wants you to cough and sneeze and poop yourself into an early grave. If it can, it wants you your blood vessels to burst and pustules to explode all over your body. Put simply, Nature is trying to kill you.

And until relatively recently, it was really good at doing this. The average life expectancy of a human in 1900 was 31 years. I should already be dead.

But then science intervened with two critical innovations, clean water and vaccines, and changed everything. Clean water has had the biggest impact, but vaccines are a close second. (more…)

Hope for a hepatitis B cure: the cunning virus that is outsmarting scientists

For World Hepatitis Day, Dr Ana Ortega-Prieto explains why she switched her research focus from hepatitis C to hepatitis B – a virus that continues its global spread despite an available vaccine. 


When I first started to work on hepatitis C virus (HCV) for my PhD, the general conviction was that it was a dangerous pathogen with very unsuccessful treatments. In the past years, this has completely changed; patients used to endure one year of treatment with severe side effects, but can now expect just three months of treatment, which is generally well tolerated. The truly impressive part here is that treatment success went up from below 50% to well over 90%. This has triggered the World Health Organisation (WHO) to aim for the eradication of all viral hepatitis by 2030 – a very ambitious goal. (more…)

World AIDS Day: Professor Robin Shattock on the elusive HIV vaccine

To mark World AIDS Day 2017, we have published a series of blog posts to highlight the important and varied research that takes places at Imperial. Three experts from Faculty of Medicine share their interest in HIV/AIDS which spans from the elusive vaccine to the economics of the epidemic.


World AIDS Day takes place annually on 1 December as an opportunity for people worldwide to unite in the fight against HIV and to show support for people living with HIV/AIDS.

Where are we in the battle against HIV/AIDS?

The past thirty years have seen enormous gains. We’ve seen the development of highly effective therapy that today can ensure the health of an HIV positive individual for rest of their natural lifespan. We used to speak of HIV/AIDS as if they were the same thing, now you can be HIV positive and never develop AIDS (Acquired Immunodeficiency Syndrome). Globally over 18 million people are now receiving life-saving drugs, preventing millions of deaths each year. Treatment also dramatically reduces the risk of passing on the infection. Excitingly, recent studies have shown that taking a daily pill (known as pre-exposure prophylaxis or PrEP) can prevent people from contracting HIV infection and this is now being made available in the UK. (more…)

World Polio Day: edging closer to eradication

As we mark the fifth annual World Polio Day, Dr Edward Parker talks about Imperial’s research supports the polio eradication initiative in a number of ways.


Imagine you are running a marathon. You have reached the final mile of a long and arduous journey. You turn the last corner expecting to see the finish line, and instead you see a huge vertical ascent. The finish line is waiting at the top, hundreds of metres above you.

Such is the plight of the Global Polio Eradication Initiative. In 1988, the year the initiative was launched, polio paralysed an estimated 350,000 people worldwide – roughly 1,000 each day. Over the last three decades, a globally coordinated vaccination campaign has fought the disease back to a few remaining refuges in Afghanistan, Pakistan, and Nigeria. In 2017, wild poliovirus has caused just 12 cases so far. (more…)